Device type · CGA
Glucose Oxidase, Glucose
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CGA
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
25
510(k), De Novo and PMA
Adverse event reports
136
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Glucose Oxidase, Glucose
- Product code
- CGA
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CGA
Latest FDA decisions
The 8 newest of 25 since 2015.
- ABL90 FLEX PLUS System510(k)
K252488 · Decided May 1, 2026 · 266 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
K210933 · Decided Sep 30, 2024 · 1,281 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
- EasyStat 300510(k)
K220328 · Decided Jul 26, 2024 · 903 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
- Cholestech LDX System510(k)
K223179 · Decided Sep 20, 2023 · 344 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
K223755 · Decided Sep 11, 2023 · 270 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
K223710 · Decided Jul 28, 2023 · 228 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
- GEM Premier ChemSTAT510(k)
K223090 · Decided Jan 27, 2023 · 119 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
K203549 · Decided Oct 18, 2022 · 683 days after receipt
Device type: Glucose Oxidase, Glucose (CGA) · Laboratory Medicine & Pathology
Reports received
136
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
133
98% of reports
Injury reports
2
1.5% of reports
Death reports
1
0.7% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 16 | 1 | 0 | 0 |
| Jan 24 | 33 | 1 | 0 | 0 |
| Feb 24 | 27 | 1 | 0 | 0 |
| Mar 24 | 26 | 2 | 0 | 0 |
| Apr 24 | 14 | 0 | 0 | 0 |
| May 24 | 27 | 0 | 0 | 0 |
| Jun 24 | 12 | 2 | 0 | 0 |
| Jul 24 | 26 | 2 | 0 | 0 |
| Aug 24 | 19 | 1 | 0 | 0 |
| Sep 24 | 14 | 2 | 0 | 0 |
| Oct 24 | 27 | 1 | 0 | 0 |
| Nov 24 | 14 | 0 | 0 | 0 |
| Dec 24 | 14 | 1 | 0 | 0 |
| Jan 25 | 10 | 0 | 0 | 0 |
| Feb 25 | 8 | 0 | 0 | 0 |
| Mar 25 | 3 | 0 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 5 | 0 | 0 | 0 |
| Jun 25 | 6 | 0 | 0 | 0 |
| Jul 25 | 5 | 1 | 0 | 0 |
| Aug 25 | 2 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 5 | 0 | 0 | 0 |
| Nov 25 | 7 | 0 | 1 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 1 | 1 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 4 | 0 | 0 | 0 |
| May 26 | 9 | 0 | 0 | 0 |
| Jun 26 | 7 | 0 | 0 | 0 |
| Jul 26 | 5 | 0 | 0 | 0 |
| Aug 26 | 6 | 1 | 0 | 0 |
| Sep 26 | 62 | 0 | 0 | 0 |
| Oct 26 | 25 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings45
- Electrical /Electronic Property Problem15
- Computer Software Problem12
- Low Readings12
- High Readings11
- Unable to Obtain Readings11
- Display or Visual Feedback Problem7
- Low Test Results7
- Battery Problem5
- Material Integrity Problem5
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions134
- Decreased Appetite1
- Hypoglycemia1
- Hypothermia1
- Insufficient Information1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2070-2025 · Started May 12, 2025 · Posted by FDA Jul 2, 2025
Reason given: Glucose microcuvettes experienced transit time outside of limits, so stability through the whole microcuvette lifetime can no longer be guaranteed. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency, and purity of...
Cause as FDA categorized it: Storage
- HEMOCUE INC F/GLUCOSE 201 ANALYZER (25/VL 4VL/BX) MICROCUVETTE.Open, Classified
Mckesson Medical-Surgical Inc. Corporate Office
Z-1827-2025 · Started Apr 24, 2025 · Posted by FDA May 27, 2025
Reason given: transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
Cause as FDA categorized it: Storage
Z-1702-2024 · Started Mar 1, 2024 · Posted by FDA Apr 30, 2024
Reason given: There is a potential that the Cholestech LDX battery (an external battery pack available as an optional accessory to the Cholestech LDX Analyzer) may swell which could cause minor burns, cuts or abrasions, or low current electrical shock to the user.
Cause as FDA categorized it: Labeling design
Z-0198-2024 · Started Sep 6, 2023 · Posted by FDA Oct 31, 2023
Reason given: RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature conditions when incorrectly. Potential to report incorrectly.
Cause as FDA categorized it: Under Investigation by firm
- RX Modena-IVD Clinical Chemistry Analyser Catalog Number: RX9000Open, Classified
Z-0201-2024 · Started Sep 6, 2023 · Posted by FDA Oct 31, 2023
Reason given: RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature conditions when incorrectly. Potential to report incorrectly.
Cause as FDA categorized it: Under Investigation by firm
- RX Monaco-IVD Clinical Chemistry Analyser Catalog Number: RX5000Open, Classified
Z-0202-2024 · Started Sep 6, 2023 · Posted by FDA Oct 31, 2023
Reason given: RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature conditions when incorrectly. Potential to report incorrectly.
Cause as FDA categorized it: Under Investigation by firm
Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.
Z-1741-2022 · Started Aug 16, 2022
Reason given: Incorrect instructions for use were packaged into the final product.
Cause as FDA categorized it: Labeling Change Control
Z-1508-2022 · Started Jun 24, 2022
Reason given: Cholesterol test cassettes package insert is to be updated with new bilirubin interference information because it was found that samples containing bilirubin, at concentrations greater than 2.0 mg/dL (conjugated) or 1.6 mg/dL (unconjugated), can result in low recovery of Triglyceride (TRG) and High-Density...
Cause as FDA categorized it: Device Design
Showing the 8 newest of 89 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.